Session Details

Driving Speed to Market Through Collaboration (Corporate Tutorial Hosted By GE Healthcare)
Thursday, May 30, 2019 12:30 PM - 01:30 PM
Room 219
Moderator:
Phil Vanek, PhD,GM, Growth Strategy, GEHC Cell and Gene Therapy, United States

Speakers:
Robin Ng, PhD, Strategy Lead, Technology and Manufacturing, Cellular Biomedicine Group, China

Rohin Iyer, PhD, Development Manager, Cell and Gene Therapy, GEHC/FastTrak@CCRM, Canada

Greg Crescenzi Enterprise Solutions Leader, GEHC Cell and Gene Therapy, United States

Effective process development and robust manufacturing are key to scaling cell and gene therapies for commercialization. A flexible solution that offers both could provide a competitive advantage. Recently, Cellular Biomedicine Group (CBMG), a clinical stage biopharmaceutical company in Shanghai, China, partnered with GE Healthcare (GEHC)’s Enterprise Solutions team as well as the Centre for Commercialization of Regenerative Medicine (CCRM) in Toronto to develop a next-generation CAR-T process based on GE’s FlexFactory equipment. Through a panel discussion they will discuss how these three teams worked together, with specific emphasis on how important logistical, technical and communication decisions were made to build a state-of-the-art CAR-T manufacturing facility/process that met CBMG’s specifications and supported their IND filing to the Chinese FDA.